Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-07-26

Clinical Trial Update: Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update describes evaluating maintenance therapy with capecitabine plus apatinib for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)
  • Capecitabine (capecitabine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN